Who makes V-5 immunitor?

V-5 immunitor is developed by Lisichansk Regional Tuberculosis Dispensary.

Last reviewed 2026-04-19 · How we verify

V-5 immunitor

Lisichansk Regional Tuberculosis Dispensary · Phase 2 active Biologic

At a glance

Generic name	V-5 immunitor
Also known as	V5, V-5 immunitor
Sponsor	Lisichansk Regional Tuberculosis Dispensary
Modality	Biologic
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

V-5 immunitor CI brief — competitive landscape report
V-5 immunitor updates RSS · CI watch RSS
Lisichansk Regional Tuberculosis Dispensary portfolio CI